Myopathy News and Research

RSS
The myopathies are neuromuscular disorders in which the primary symptom is muscle weakness due to dysfunction of muscle fiber. Other symptoms of myopathy can include include muscle cramps, stiffness, and spasm. Myopathies can be inherited (such as the muscular dystrophies) or acquired (such as common muscle cramps).
KIT researchers use high-resolution microscopy to uncover how scavenger cells repair muscle fibers

KIT researchers use high-resolution microscopy to uncover how scavenger cells repair muscle fibers

Consensus paper on atrial cardiomyopathies could be important step forward for research, treatment

Consensus paper on atrial cardiomyopathies could be important step forward for research, treatment

Wolff-Parkinson-White patients continue to have atrial fibrillation risk even after catheter ablation, study finds

Wolff-Parkinson-White patients continue to have atrial fibrillation risk even after catheter ablation, study finds

Renal risk factors for NA-treated HBV patients identified

Renal risk factors for NA-treated HBV patients identified

Study: Delirium, muscle weakness and other neurological complications of sepsis poorly understood

Study: Delirium, muscle weakness and other neurological complications of sepsis poorly understood

Berlin researchers identify defects in myotubular myopathy

Berlin researchers identify defects in myotubular myopathy

Could statins treat muscular dystrophy? An interview with Dr. Nick Whitehead and Dr Stan Froehner

Could statins treat muscular dystrophy? An interview with Dr. Nick Whitehead and Dr Stan Froehner

Researchers unlock structural details of key protein to treat neuromuscular disease

Researchers unlock structural details of key protein to treat neuromuscular disease

Research highlights potential new treatment strategy for degenerative diseases

Research highlights potential new treatment strategy for degenerative diseases

First patient dosed in long term-safety extension study of Resolaris for adult patients with FSHD

First patient dosed in long term-safety extension study of Resolaris for adult patients with FSHD

Scientists reveal role of dynamin and show how specific mutations impair function of dynamin

Scientists reveal role of dynamin and show how specific mutations impair function of dynamin

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

Necrotising autoimmune myopathy requires early, aggressive treatment

Necrotising autoimmune myopathy requires early, aggressive treatment

Substantial pharmacogenetic information available on cardiovascular drugs

Substantial pharmacogenetic information available on cardiovascular drugs

Clementia Pharmaceuticals commences multi-center study of patients with fibrodysplasia ossificans progressiva

Clementia Pharmaceuticals commences multi-center study of patients with fibrodysplasia ossificans progressiva

aTyr's Resolaris granted FDA Orphan Drug Designation for treatment of FSHD

aTyr's Resolaris granted FDA Orphan Drug Designation for treatment of FSHD

Joseph Roche receives grant to develop improved exercise programs for people with dysferlinopathies

Joseph Roche receives grant to develop improved exercise programs for people with dysferlinopathies

TGen scientists discover the likely cause of rare type of muscle weakness in six children

TGen scientists discover the likely cause of rare type of muscle weakness in six children

EC grants orphan drug designation to aTyr Pharma's Resolaris for treatment of FSHD

EC grants orphan drug designation to aTyr Pharma's Resolaris for treatment of FSHD

Clementia secures additional $10 million to support development of palovarotene for treatment of FOP

Clementia secures additional $10 million to support development of palovarotene for treatment of FOP